# Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease

> **NCT05495698** · NA · RECRUITING · sponsor: **Franciscus Gasthuis** · enrollment: 300 (estimated)

## Conditions studied

- Copd
- Adherence, Medication

## Interventions

- **DRUG:** single-inhaler triple therapy (Trimbow)
- **DEVICE:** E-health application: Curavista app & FindAir e-device
- **DRUG:** multi-inhaler triple therapy (Qvar + Bevespi)

## Key facts

- **NCT ID:** NCT05495698
- **Lead sponsor:** Franciscus Gasthuis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-13
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495698, "Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05495698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*